Shenzhen S.E.
03:30:00 24/05/2024 am IST
5-day change
1st Jan Change
39.71
CNY
+0.23%
-3.00%
+14.57%
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 25, 2021 at 05:21 pm IST
Sirio Pharma Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,165.031 million compared to CNY 915.765 million a year ago. Operating income was CNY 173.489 million compared to CNY 153.326 million a year ago. Net income was CNY 145.779 million compared to CNY 124.249 million a year ago. Basic earnings per share from continuing operations was CNY 0.81 compared to CNY 0.69 a year ago. Diluted earnings per share from continuing operations was CNY 0.79 compared to CNY 0.69 a year ago.
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
21/04
CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.
19/03
CI
Sirio Pharma Co., Ltd.'s Equity Buyback announced on September 15, 2023, has closed with 1,285,600 shares, representing 0.71% for CNY 39.9 million.
18/03
CI
Tranche Update on Sirio Pharma Co., Ltd.'s Equity Buyback Plan announced on September 15, 2023.
02/01
CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
25/23/25
CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.
25/23/25
CI
Sirio Pharma Co., Ltd.(XSEC:300791) added to S&P Global BMI Index
18/23/18
CI
Sirio Pharma Co., Ltd. announces an Equity Buyback for CNY 40 million worth of its shares.
15/23/15
CI
Sirio Pharma Co., Ltd. authorizes a Buyback Plan.
14/23/14
CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
24/23/24
CI
Sirio Pharma Co., Ltd. Announces Implementation of Cash Dividend for the Year 2022, Payable on June 07, 2023
02/23/02
CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
27/23/27
CI
Sirio Pharma Co., Ltd. Proposes Profit Distribution Proposal of Cash Dividend for the Year 2022
22/23/22
CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
20/23/20
CI
Sirio Pharma Co., Ltd.(XSEC:300791) dropped from S&P Global BMI Index
19/22/19
CI
Sirio Pharma Cancels Planned 1.35 Billion Yuan Share Sale to Fund Aquisition
09/22/09
MT
Sirio Pharma Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
25/22/25
CI
Sirio Pharma Co., Ltd. acquired 80% stake in Best Formulations Inc. from m Eugene C. Ung, Kelly C. Ung, Charles C. Ung, Peak Trust Company-NV, Jeffrey A. Goh, and Joy S. Hsu.
17/22/17
CI
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2022.
25/22/25
CI
Sirio Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
25/22/25
CI
Sirio Pharma to Buy 80% of US Rival Best Formulations for $180 Million; Shares Slump 4%
11/22/11
MT
Sirio Pharma Plans to Raise Up to CNY 1.35 Billion in Share Private Placement
07/22/07
CI
Sirio Pharma Co., Ltd. agreed to acquire 80% stake in Ultimate Formulations, Inc.
07/22/07
CI
Sirio Pharma Co., Ltd. announced that it expects to receive CNY 1.35 billion in funding
06/22/06
CI
Sirio Pharma Co., Ltd. Announces Final Profit Distribution Plan for 2021 on A Shares, Payable on 23 May 2022
18/22/18
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Sirio Pharma Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of nutritional health food. The Company's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The Company's own brand is WEWOW nutritional health food. The Company distributes its products both in the domestic market and to overseas markets.
More about the company
Last Close Price
39.71
CNY
Average target price
41.67
CNY
Spread / Average Target
+4.93%
Consensus
1st Jan change
Capi.
+14.57% 99Cr +13.97% 820.31Cr +5.29% 761.21Cr +0.60% 595.4Cr -6.04% 372.06Cr -10.75% 356.97Cr -7.53% 127.17Cr -29.55% 107.47Cr -12.85% 89Cr -18.06% 79Cr
Special Foods & Wellbeing Products
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
SIRIO PHARMA CO., LTD. 
